Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3286344rdf:typepubmed:Citationlld:pubmed
pubmed-article:3286344lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3286344lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:3286344lifeskim:mentionsumls-concept:C0041427lld:lifeskim
pubmed-article:3286344lifeskim:mentionsumls-concept:C0033362lld:lifeskim
pubmed-article:3286344lifeskim:mentionsumls-concept:C0277785lld:lifeskim
pubmed-article:3286344lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:3286344lifeskim:mentionsumls-concept:C1522602lld:lifeskim
pubmed-article:3286344lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:3286344pubmed:issue3lld:pubmed
pubmed-article:3286344pubmed:dateCreated1988-6-30lld:pubmed
pubmed-article:3286344pubmed:abstractTextGlucose tolerance and insulin secretion were studied in two groups of non-diabetic identical twins of recently-diagnosed Type 1 (insulin-dependent) diabetic patients: (1) a group of 5 twins with islet cell antibodies, and (2) a group of 6 twins without. Despite similar fasting glucose, insulin and C-peptide concentrations both groups of twins had significantly higher fasting proinsulin concentrations than the control group (p less than 0.05). The twins with complement-fixing islet cell antibodies had reduced glucose tolerance and clearance, whilst the twins without islet cell antibodies did not. Neither group of twins showed any abnormality in insulin, C-peptide or proinsulin response to oral or intravenous glucose. We conclude that increased fasting proinsulin levels precede abnormalities of insulin secretion, and are an early indication of minor B-cell damage in these twins irrespective of their risk of developing diabetes.lld:pubmed
pubmed-article:3286344pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3286344pubmed:languageenglld:pubmed
pubmed-article:3286344pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3286344pubmed:citationSubsetIMlld:pubmed
pubmed-article:3286344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3286344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3286344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3286344pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3286344pubmed:statusMEDLINElld:pubmed
pubmed-article:3286344pubmed:monthMarlld:pubmed
pubmed-article:3286344pubmed:issn0012-186Xlld:pubmed
pubmed-article:3286344pubmed:authorpubmed-author:HalesC NCNlld:pubmed
pubmed-article:3286344pubmed:authorpubmed-author:PykeD ADAlld:pubmed
pubmed-article:3286344pubmed:authorpubmed-author:LeslieR DRDlld:pubmed
pubmed-article:3286344pubmed:authorpubmed-author:TurEElld:pubmed
pubmed-article:3286344pubmed:authorpubmed-author:MillwardB ABAlld:pubmed
pubmed-article:3286344pubmed:authorpubmed-author:GrayI PIPlld:pubmed
pubmed-article:3286344pubmed:authorpubmed-author:HeatonD ADAlld:pubmed
pubmed-article:3286344pubmed:issnTypePrintlld:pubmed
pubmed-article:3286344pubmed:volume31lld:pubmed
pubmed-article:3286344pubmed:ownerNLMlld:pubmed
pubmed-article:3286344pubmed:authorsCompleteYlld:pubmed
pubmed-article:3286344pubmed:pagination182-4lld:pubmed
pubmed-article:3286344pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:3286344pubmed:meshHeadingpubmed-meshheading:3286344-...lld:pubmed
pubmed-article:3286344pubmed:meshHeadingpubmed-meshheading:3286344-...lld:pubmed
pubmed-article:3286344pubmed:meshHeadingpubmed-meshheading:3286344-...lld:pubmed
pubmed-article:3286344pubmed:meshHeadingpubmed-meshheading:3286344-...lld:pubmed
pubmed-article:3286344pubmed:meshHeadingpubmed-meshheading:3286344-...lld:pubmed
pubmed-article:3286344pubmed:meshHeadingpubmed-meshheading:3286344-...lld:pubmed
pubmed-article:3286344pubmed:meshHeadingpubmed-meshheading:3286344-...lld:pubmed
pubmed-article:3286344pubmed:meshHeadingpubmed-meshheading:3286344-...lld:pubmed
pubmed-article:3286344pubmed:meshHeadingpubmed-meshheading:3286344-...lld:pubmed
pubmed-article:3286344pubmed:meshHeadingpubmed-meshheading:3286344-...lld:pubmed
pubmed-article:3286344pubmed:meshHeadingpubmed-meshheading:3286344-...lld:pubmed
pubmed-article:3286344pubmed:meshHeadingpubmed-meshheading:3286344-...lld:pubmed
pubmed-article:3286344pubmed:meshHeadingpubmed-meshheading:3286344-...lld:pubmed
pubmed-article:3286344pubmed:year1988lld:pubmed
pubmed-article:3286344pubmed:articleTitleIncreased proinsulin levels as an early indicator of B-cell dysfunction in non-diabetic twins of type 1 (insulin-dependent) diabetic patients.lld:pubmed
pubmed-article:3286344pubmed:affiliationDepartment of Medicine, King's College Hospital, London, UK.lld:pubmed
pubmed-article:3286344pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3286344pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3286344lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3286344lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3286344lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3286344lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3286344lld:pubmed